From Fetal-maternal Interface Immune Tolerance to Endometrial Cancer Immune Escape: Potential Targets for Immunotherapy

NCT06273878 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2024-02-23

No results posted yet for this study

Summary

Non-interventional retro-prospective study on Endometrial tissue samples taken from surgically treated patients.

Conditions

Sponsors & Collaborators

  • Università degli Studi dell'Insubria

    collaborator OTHER
  • Regina Elena Cancer Institute

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-15
Primary Completion
2025-01-15
Completion
2025-01-15

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06273878 on ClinicalTrials.gov